Hematological Disorders in Patients With GI Angiodysplasia

N/ANot Yet RecruitingNCT07183995

Assiut University55 enrolled

Overview

The aim of this study will be to assess the association between GIT angiodysplasia with any hematological disorders as von Willebrand factor and Prognostic value of von Willebrand factor on patient's outcomes as risk of rebleeding and hospital mortality

Study Type

OBSERVATIONAL

Enrollment

Conditions

GI Bleeding

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: Adults (above 18 years) and elderly Both genders Admitted to GIT Unit with manifestations of GIT bleeding diagnosed by upper endoscopy and Colonoscopy as angiodyplasia. \- Exclusion Criteria: other causes of GIT bleeding \-

Outcomes

Primary Outcomes

Correlation between GIT Angiodysplasia and Hematological disorders

All patients eligible to participate will undergo the following: 1. upper endoscopy 2. Colonoscopy 3. Complete blood count, CRP 4. D-Dimer, liver function tests, blood Urea and serum Creatinine 5. ECG 6. Coagulation profile (aPTT , von Willebrand factor activity \&antigen)

Time frame: Baseline

Secondary Outcomes

Prevelance of different hematological disorders in angiodysplasia patients

Time frame: Baseline

Prognostic value of von Willebrand factor on patient's outcomes as risk of rebleeding and hospital mortality

Time frame: Baseline

Central Contacts

Mennat-allah Alaa Abdelgaber, Resident

CONTACT

+201021789585 Menna.17289695@med.aun.edu.eg

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.